Literature DB >> 1596684

Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta.

F Plane1, K R Bruckdorfer, P Kerr, A Steuer, M Jacobs.   

Abstract

1. The mechanism by which Cu(2+)-oxidized low-density lipoproteins (oxLDL) inhibit acetylcholine (ACh)-evoked relaxations mediated by endothelium-derived nitric oxide (EDRF) in rabbit aortic rings was investigated. The proposed role of lysophosphatidylcholine (LPC) in the inhibition was also studied. 2. The kinetics of lipid peroxidation of native low-density lipoproteins (LDL) from individual donors, as measured by changes in conjugated diene concentration, were related to the inhibitory effects of the resultant oxLDL. It was found that the more susceptible LDL was to oxidation, the greater the inhibition. 3. No correlation was found between the inhibitory effects of oxLDL and LPC content. 4. Synthetic 1-palmitoyl LPC produced an inhibition of ACh-induced relaxations and when added to precontracted rings evoked nitric oxide-mediated endothelium-dependent relaxation. This latter effect was not elicited by oxLDL. 5. Synthetic 1-palmitoyl (10 microM) had no effect on relaxations evoked by glyceryl trinitrate in endothelium-denuded aortic rings in contrast to the inhibition found previously for oxLDL. 6. Concentrations of oxLDL and phospholipase A2-treated LDL which inhibited relaxation contained very different LPC concentrations. Unlike oxLDL, the inhibitory effects of phospholipase A2-treated LDL preparations were independent of the donors and showed no lag period. 7. We suggest that there are differences in the mechanisms by which oxLDL and 1-palmitoyl LPC exert their inhibitory effects on relaxation. 8. The inhibition of relaxation by oxLDL (1-2 mg protein ml-1) was prevented by the presence of high-density lipoproteins (HDL; 1-2 mg protein ml-1).9. It is proposed that prevention of the inhibition of relaxation by HDL is consistent with the inhibitory factor(s) being lipophilic constituents of oxLDL. However, variations in the inhibitory effects of oxLDL preparations are not due to differences in their LPC content and factors other than LPC must contribute to the inhibition.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1596684      PMCID: PMC1908615          DOI: 10.1111/j.1476-5381.1992.tb14237.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

Review 2.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

Review 3.  Biochemical, structural, and functional properties of oxidized low-density lipoprotein.

Authors:  H Esterbauer; M Dieber-Rotheneder; G Waeg; G Striegl; G Jürgens
Journal:  Chem Res Toxicol       Date:  1990 Mar-Apr       Impact factor: 3.739

4.  Quantitative analysis of phospholipids by thin-layer chromatography.

Authors:  V P Skipski; R F Peterson; M Barclay
Journal:  Biochem J       Date:  1964-02       Impact factor: 3.857

5.  Lipid hydroperoxide involvement in copper-dependent and independent oxidation of low density lipoproteins.

Authors:  C E Thomas; R L Jackson
Journal:  J Pharmacol Exp Ther       Date:  1991-03       Impact factor: 4.030

6.  Lysolecithins as endothelium-dependent vascular smooth muscle relaxants that differ from endothelium-derived relaxing factor (nitric oxide)

Authors:  T Saito; A Wolf; N K Menon; M Saeed; C Alves; R J Bing
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

7.  Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor.

Authors:  J Galle; A Mülsch; R Busse; E Bassenge
Journal:  Arterioscler Thromb       Date:  1991 Jan-Feb

8.  Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.

Authors:  M E Rosenfeld; J C Khoo; E Miller; S Parthasarathy; W Palinski; J L Witztum
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Impaired endothelium-dependent relaxation to aggregating platelets and related vasoactive substances in porcine coronary arteries in hypercholesterolemia and atherosclerosis.

Authors:  H Shimokawa; P M Vanhoutte
Journal:  Circ Res       Date:  1989-05       Impact factor: 17.367

10.  Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta.

Authors:  J P Cooke; N A Andon; X J Girerd; A T Hirsch; M A Creager
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

View more
  13 in total

Review 1.  Lipids and endothelium-dependent vasodilation--a review.

Authors:  Lars Lind
Journal:  Lipids       Date:  2002-01       Impact factor: 1.880

2.  The impairment of endothelium-dependent arterial relaxation by 7-ketocholesterol is associated with an early activation of protein kinase C.

Authors:  Valérie Deckert; Linda Duverneuil; Sandrine Poupon; Serge Monier; Naig Le Guern; Gérard Lizard; David Masson; Laurent Lagrost
Journal:  Br J Pharmacol       Date:  2002-11       Impact factor: 8.739

Review 3.  Antioxidants, lipoprotein oxidation, and arterial function.

Authors:  K R Bruckdorfer
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

4.  Coronary flow reserve.

Authors:  P Collins
Journal:  Br Heart J       Date:  1993-04

5.  Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein.

Authors:  J K Liao; S L Clark
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

6.  The vascular activity of some isoflavone metabolites: implications for a cardioprotective role.

Authors:  J P Chin-Dusting; L J Fisher; T V Lewis; A Piekarska; P J Nestel; A Husband
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

7.  Oxidized low-density lipoprotein inhibits nitric oxide-mediated coronary arteriolar dilation by up-regulating endothelial arginase I.

Authors:  Wei Wang; Travis W Hein; Cuihua Zhang; David C Zawieja; James C Liao; Lih Kuo
Journal:  Microcirculation       Date:  2011-01       Impact factor: 2.628

8.  Detrimental vascular effects of lysophosphatidylcholine is limited by other phospholipid components of low-density lipoprotein.

Authors:  Susan W S Leung; Min Huang; Ricky Y K Man
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

9.  Effects of ACE inhibitors on oxidation of human low density lipoprotein.

Authors:  E G Godfrey; J Stewart; H J Dargie; J L Reid; M Dominiczak; C A Hamilton; J McMurray
Journal:  Br J Clin Pharmacol       Date:  1994-01       Impact factor: 4.335

10.  Chelation of copper reduces inhibition by oxidized lipoproteins of endothelium-dependent relaxation in porcine coronary arteries.

Authors:  T Hayashi; T Ishikawa; M Kuzuya; M Naito; K Yamada; K Asai; H Hidaka; A Iguchi
Journal:  Heart Vessels       Date:  1994       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.